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ORIGINAL ARTICLE
Incidence of individual organ dysfunction in fatal acute pancreatitis:
analysis of 1024 death records
Damian J. Mole, Bayanne Olabi, Victoria Robinson, O. James Garden & Rowan W. Parks
Department of Clinical and Surgical Sciences (Surgery), University of Edinburgh, Edinburgh, UK
Abstract
Background: Extrapancreatic organ dysfunction is the key determinant of mortality in acute pancreatitis
(AP). This study aimed to document the frequency and duration of individual organ dysfunction in all
fatalities caused by AP in a large, population-based cohort.
Methods: All deaths caused by AP in Scotland between 2000 and 2006 inclusive were analysed
(n = 1024).
Results: The median time lapse between the onset of AP and death was 6 days (interquartile range [IQR]
17 days); that between the onset of organ dysfunction and death was 3 days (IQR 7 days). There was no
apparent bimodal distribution. The majority of patients had single- (384 patients) or two-system (242
patients) extrapancreatic organ dysfunction. Pulmonary dysfunction was most prevalent (30% of organ-
specific entries, 198/660), followed by cardiovascular (18%, 117/660), renal (16%, 108/660), liver (11%,
71/660), gastrointestinal (9%, 59/660), haemorrhage (6%, 38/660), coagulopathy (5%, 31/660) and
central nervous system (6%, 38/660) dysfunction.
Conclusions: Death in AP occurs early in the disease course. The present findings support the primacy
of pulmonary injury as the modal pattern of organ dysfunction in severe AP, with increased frequencies of
cardiovascular and renal compromise in fatal AP.
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Introduction
Acute pancreatitis (AP) is inflammation of the pancreas usually
caused by gallstones or excessive consumption of alcohol.1 The
natural history of AP is that of a self-resolving clinical course in
approximately 80% of episodes.2 Those patients who develop per-
sistent extrapancreatic organ dysfunction (and who are therefore
categorized as having severe AP) will usually require level 2 (high-
dependency unit) or level 3 (intensive care unit) critical care
support, with substantial costs to the health care service.3 The
presence of persistent multiple organ failure is the key determi-
nant of mortality in AP and analyses of prospectively collected
data, such as those from the West of Scotland Pancreatic Unit,
Glasgow,4 or the post hoc analysis of participants in the lexipafant
trial reported by Johnson and Abu-Hilal (2004),5 emphasize the
fundamental relationship between persistent organ failure and
death. This notion is recapitulated in larger, retrospective analyses,
including one from our own unit.6 The pathogenesis of systemic
complications, specifically extrapancreatic acute organ dysfunc-
tion, is incompletely understood and further definition of the
mechanisms of AP-associated organ failure is the focus of ongoing
preclinical research. To facilitate service planning and to focus
translational research studies, epidemiological data for individual
organ dysfunction in severe AP are extremely helpful. In this
study, we sought to document the frequency and duration of
individual organ dysfunction in all fatalities caused by AP in a
large national cohort.
This study was presented in part at the European Pancreatic Club Meeting,
Newcastle-upon-Tyne, 5–6 July 2007.
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Materials and methods
Confirmation that formal ethical approval was not required for
this study was obtained following consultation with a local ethics
committee representative and the General Register Office for Scot-
land. All deaths in Scotland between January 2000 and December
2005 inclusive (population: 5.06 million in 2001 and 5.12 million
in 2006)7 for which AP (ICD-10 code K85) was registered as
the primary or underlying cause of death were extracted from the
General Register Office for Scotland. Detailed entries from the
death register were computer-searched for the mention of any of
the keywords listed below. The spreadsheet of positive hits was
scrutinized and the diagnosis of AP and mention of specific organ
failure verified manually. The Boolean operators used for the
computer search are given in upper case.
1 Multiple-organ failure, using the terms: ‘multiple (OR multi-)
organ failure’; ‘multi-system organ failure’; ‘multi-organ dys-
function (syndrome)’, and ‘systemic inflammatory response
syndrome’.
2 Respiratory system failure or lung injury, using the terms:
‘respiratory failure’; ‘adult (OR acute) respiratory distress syn-
drome’; ‘(acute) pulmonary oedema’; ‘(broncho-) pneumo-
nia’, and ‘pleural effusion’. Chronic obstructive pulmonary
disease and exacerbations thereof were regarded as premorbid
conditions and were not included as indicators of acute organ
dysfunction.
3 Cardiovascular compromise, using the terms: ‘acute myocar-
dial ischaemia (OR infarction)’; ‘acute cardiac event’; ‘acute
coronary syndrome’; ‘cardiac (OR left ventricular) failure’;
‘cardiac tamponade’, and ‘cardiogenic shock’. ‘Cardiac (OR
cardiorespiratory) arrest’ was regarded as the mode of death
rather than the cause and not included as an individual organ
dysfunction. Ischaemic heart disease, atherosclerosis and
hypertension were regarded as comorbid conditions and not
included as indicators of acute organ dysfunction.
4 Renal dysfunction, using the terms: ‘(acute) renal failure’, and
‘(acute) hepato-renal syndrome’. Chronic renal failure or
impairment was regarded as a premorbid condition.
5 Haemorrhage, using the terms: ‘(acute) haemorrhage’; ‘exsan-
guination’; ‘(upper OR lower) gastrointestinal bleed (OR
haemorrhage)’; ‘haematemesis’, and ‘(massive OR uncontrol-
lable) intra-abdominal bleed (OR haemorrhage)’. The term
‘acute haemorrhagic pancreatitis’ without further qualifica-
tion was not taken to indicate acute bleeding.
6 Coagulopathy, using the terms: ‘coagulopathy’; ‘disseminated
intravascular coagulation’; ‘portal vein thrombosis’, and ‘deep
vein thrombosis’.
7 Gut injury or dysfunction, using the terms: ‘perforated duode-
nal (OR gastric) ulcer (OR hollow viscus)’; ‘gastrointestinal
bleed (OR haemorrhage)’; ‘bowel (ORmesenteric) ischaemia’;
‘colonic infarction’; ‘bowel obstruction (OR perforation)’, and
‘ileus’.
8 Liver and biliary dysfunction/injury, using the terms: ‘acute
(OR ascending) cholangitis’; ‘(acute) liver (OR hepatic)
failure’; ‘hepato-renal syndrome’; ‘jaundice’; ‘hepatitis’, and
‘hepatic necrosis’. Alcoholic liver disease was regarded as a
comorbid condition.
9 Central nervous system involvement, using the terms: ‘cere-
brovascular accident (OR event)’; ‘stroke’; ‘intracranial bleed
(OR haemorrhage)’; ‘anoxic (OR hypoxic) brain injury’;
‘brainstem haemorrhage’, and ‘cerebral infarction (OR
infarct)’.
10 Sepsis or infection, using the terms: ‘abscess’; ‘infected (OR
infection)’; ‘sepsis (OR septic)’; ‘septicaemia’; ‘suppurative’,
and ‘pus (OR purulent)’.
11 Assumed aetiology, using the terms: ‘gallstones’; ‘cholelithiasis’,
and ‘biliary stones (OR calculi)’ for gallstones, and ‘alcohol’
OR ‘alcoholism’ and ‘endoscopic retrograde cholangiopancre-
atography’. Chronic pancreatitis was regarded as a premorbid
condition and was not included in this analysis.
The statistics presented are largely descriptive. The variable ‘age’
did not follow a normal distribution by the Kolmogorov–Smirnov
test and therefore the Mann–Whitney U-test was applied with an
assumed significance level of0.05 (spssVersion 14.0; SPSS, Inc.,
Chicago, IL, USA).
Results
In this study, 1024 patients were identified and all records were
analysed. The demographics of the cohort are presented in
Table 1. Males died at a significantly younger age than females
(males: median age at death 67 years, interquartile range [IQR] 23
years; females: median age at death 78 years, IQR 17 years;
P < 0.001, Mann–Whitney U-test). The male : female ratio in the
cohort by type of organ failure recapitulated that of the cohort as
a whole (Table 1). There was no significant difference in number
of deaths per year during the period studied (data not shown).
The median time interval recorded between the onset of AP and
Table 1 Patient demographics
Male Female Total Significance
Total number (%) 502 (49%) 522 (51%) 1024 (100%)
Median age, years (IQR) 67 (23) 78 (17) 73 (22) P < 0.001a
Number with organ failure recorded (%) 351 368 719 (70%)
aMann–Whitney U-test
IQR, interquartile range
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death was 6 days (IQR 17 days); that between the onset of organ
dysfunction and death was 3 days (IQR 7 days). Figure 1 depicts
the distribution of duration between onset of AP and death and
does not appear to show a bimodal distribution in this
population-based cohort.
Multiplicity of organ failure (number of organs failing in any
one individual) is presented in Table 2. The majority of patients
had single- (384 patients) or two-system (242 patients) extrapan-
creatic organ dysfunction. The relative frequencies of specific
organ dysfunction are presented in Table 3. Pulmonary dysfunc-
tion was most prevalent (30% of patients, 198/660), followed by
cardiovascular and renal dysfunction (18%, 117/660 and 16%,
108/660, respectively). Liver and gastrointestinal dysfunction
affected 11% (71/660) and 9% (59/660) of patients, respectively,
and the remainder of specific organ failures were recorded as
haemorrhage, coagulopathy and central nervous system dysfunc-
tion (6% [38/660], 5% [31/660] and 6% [38/660], respectively).
The aetiology of pancreatitis was not well recorded; reliable
entries (as judged by the authors) were available only for 248 of
1024 patients. The relative proportions of gallstone, alcohol and
post-endoscopic retrograde cholangiopancreatography aetiology
in this group were 50% (124/248), 46% (115/248) and 4%
(9/248), respectively. Idiopathic AP was incorporated in the group
with unclear aetiology.
Discussion
In this study, we report the incidence of individual organ dysfunc-
tion in a large retrospective cohort of all AP fatalities in Scotland
registered between 2000 and 2005. The main findings show that
63% of fatalities had dysfunction of at least two organ systems,
and that the pulmonary system was most frequently injured, fol-
lowed by the cardiovascular and renal systems, usually in a cumu-
lative fashion.
Strengths of this study include the fact that we examined all
deaths from AP in Scotland over a 6-year period, minimizing any
selection and reporting bias that might arise in single-centre
reports or in data from prospective trials of potential therapies.
Further strengths lie in the large size of the cohort and the fact that
it included the entire population of a clearly defined geographical
area. The process of data management after initial completion of
the death certificate is internally validated at the General Register
Office for Scotland and subject to regular quality control.
There are some potential limitations to the approach used in
this study. First and foremost, this study relies entirely on the
accuracy and completeness of the registration of underlying
causes of death on the death certificate, which, although it has
been shown to be accurate in the majority of cases, is a potential
source of error.8 Indices of agreement between causes of death
stated on death certificates vary widely and have been reported to
depend on several factors, including: the nature of disease (e.g. the
agreement index for neoplastic diseases has been reported to be
83%, compared with 31% for chest diseases);9 the duration of
hospitalization before death (longer periods correlate with higher
agreement indices), and the involvement of alcohol.10 Acute pan-
creatitis is an acute disease, usually with a short duration of hos-
pital admission before death, is non-neoplastic and often involves
alcohol, and therefore may exhibit a low death certificate agree-
ment index. Despite these limitations, analyses of death certifi-
cates have been shown to serve the reporting of mortality statistics
and demographics appropriately, as emphasized by Lahti and
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Figure 1 Histogram depicting time from onset of acute pancreatitis
to death
Table 2 Multiplicity of organ failure
Number of organs failing concurrently Frequency
in cohort
%
Multiple (number not specified) 305 30
1 384 38
2 242 24
3 89 9
4 3 <1
5 1 <1
Total 1024
Table 3 Specific organ dysfunction
Number
of episodes
%
Pulmonary 198 30
Cardiovascular 117 18
Renal 108 16
Liver 71 11
Gut 59 9
Haemorrhage 38 6
Coagulation 31 5
Central nervous system 38 6
Total 660 100
168 HPB
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Penttila (2001),11 and are extremely useful in population-based
studies as they minimize selection and reporting bias.
The present findings concur with those of previous studies.
Individual organ failure (classified using the Marshall score12) in
290 patients recruited to the lexipafant study with a predicted
severe attack, using an APACHE II score >6 at presentation, was
broken down by Johnson and Abu-Hilal (2004) into transient
organ failure (resolving in <48 hours) and persistent organ failure
(duration >48 hours).5 Organs involved in patients with transient
organ failure (71 patients) were: pulmonary in 86%; renal in 4%;
coagulopathy-related in 4%, pulmonary and renal in 4%, and
pulmonary and coagulopathy-related in 1%. In the 40 patients
who died, organs involved in week 1 were: pulmonary in 25%;
renal in 5%; pulmonary and renal in 30%, and three or more
systems-related in 33%.5 Similarly, in an analysis of 121 patients
with organ failure studied as part of a randomized, controlled trial
conducted in the West of Scotland Pancreatic Unit between 1997
and 1999, the following incidences of individual organ dysfunc-
tion were noted: pulmonary in 37%; renal in 9%; coagulation-
related in 11%; brain in 2%, and cardiovascular in 5%. In that
series, the mortality rate in patients with single organ dysfunction
was 2.5%, compared with 69% in patients with dysfunction of two
or more organs.4,13 It is possible that the increased incidence of
renal and cardiorespiratory failure in the present study compared
with the aforementioned studies reflects the uniformly fatal
nature of the episodes in our series.
With respect to pulmonary failure, the agreement between the
data presented in this study and data from other groups reinforces
the prime importance of lung injury in severe AP. Pulmonary
infiltrates are seen on chest radiographs in 6–26% of all patients
with AP14 and an abnormal chest radiograph has been associated
with a relative risk of death 15 times that of patients with a normal
chest radiograph.15 The reasons why the lung is the most com-
monly injured organ system in severe AP are not completely
understood, but preventing acute lung injury is arguably the most
logical target of potential therapy. Several hypotheses regarding
the inception of respiratory dysfunction in AP exist, including
compromised ventilation,14 impaired alveolar gas exchange16 and
increased permeability to plasma proteins.14 Furthermore, AP
results in an increased susceptibility to infection,17 and established
AP-related organ failure is associated with a diminished pro-
inflammatory cytokine response to lipopolysaccharide.18 Current
studies are exploring the hypothesis that mesenteric lymph-
carrying cytotoxic kynurenine catabolites of tryptophan to the
pulmonary capillary bed form an integral component of the
complex pathogenesis of pancreatitis-associated organ failure.19
An interesting observation of this population-based study con-
cerned the absence of a bimodal temporal distribution of deaths.
It is possible that the bimodal distribution observed in previous
studies13 may be a function of the receipt of a tertiary referral
cohort from the general hospital population, and thus subject to
referral bias. Tertiary referral centres usually also have their own
emergency intake, which generates a proportion of early deaths,
but also receive a disproportionately greater number of tertiary
referrals with infected (or non-infected) necrosis, who die after
longer time intervals, giving the impression of two peaks. The
absence of a clear bimodal distribution in the present study
appears to indicate that using population data (rather than insti-
tutional data) might encourage greater emphasis on supporting
and preventing organ dysfunction during the critical illness phase
and less emphasis on the use of prophylactic therapies for late
sepsis.
In conclusion, this population-based study of 1024 deaths from
AP occurring over a 6-year period provides epidemiological data
regarding patterns of individual organ dysfunction in fatal AP.
Death in AP occurs early in the disease course. The findings
support the primacy of pulmonary injury as the modal pattern of
organ dysfunction in severe AP, with an increased frequency of
cardiovascular and renal compromise in fatal episodes.
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